Tag: Synchron

Stentrode brain-computer interface receives breakthrough device designation from FDA

The US Food and Drug Administration (FDA) has granted breakthrough device designation to the Stentrode brain-computer interface for its fully-implantable medical device that can...

LIVE from SNIS: Endovascular brain-computer interface improves function in paralysed patient

According to late-breaking data presented at the Society of NeuroInterventional Surgery’s (SNIS) 17th Annual Meeting, a wireless endovascular brain–computer interface (BCI) “may improve capacity to perform activities in daily living...
synchron funding for stentrode

Synchron secures funding to advance commercialisation of Stentrode

Synchron has been awarded nearly AUD$1M ($990,000) in funding from the Medical Research Future Fund (MRFF), through MTPConnect, the Australian Government’s BioMedTech Horizons (BMTH)...

BIBA Briefings: Novel device seeks to overcome paralysis by “bypassing” nervous...

Synchron recently announced the first successful implant of its minimally-invasive neural interface technology (Stentrode) as part of a trial evaluating the safety and efficacy of...